Enhancing antitumor efficacy of CLDN18.2-directed antibody-drug conjugates through autophagy inhibition in gastric cancer
Wenjing Xue(Hunan University), Xuyao Zhang(Chinese Academy of Sciences)
Cited by 39
Related Papers
TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer
|Journal of Nanobiotechnology|2023|85
Cell Membrane-Derived Vesicle: A Novel Vehicle for Cancer Immunotherapy
|Frontiers in Immunology|2022|27
A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE
|Cell Death and Disease|2024|22